The small molecule axl inhibitor BGB324 shows activity against T315I-mutated and BCR-ABL1 wt chronic myeloid leukemia
Robert Erdmann,Heather G. Jørgensen,Isabel Ben-Batalla, N Kruse,David R. Micklem,G Von Amsberg,Philippe Schafhausen,Alexander Schultze,Mark Wroblewski,Michele D. Binder,Miguel Cubas-Cordova, T Hadlich, M Janing,Stefanie Sawall, Witzke,James B. Lorens,Elaine K. Allan,Leena Mukherjee,Heather Morrison, J Cassells, N Koerger,Richard E. Clark,Steffen Koschmieder,Peter Vandenberghe, Tim H. Bruemmendorf,Andreas Hochhaus,Peter Carmeliet,Tessa L. Holyoake,Klaus Pantel, Carsten Bokemeyer,Sonja Loges ONCOLOGY RESEARCH AND TREATMENT（2014）
Key words
chronic myeloid leukemia,i-mutated,bcr-abl
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
